The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - AstraZeneca; Roche
Speakers' Bureau - AstraZeneca; Roche
The GATTO study: A phase I of the anti-MUC1 Gatipotuzumab (GAT) in combination with the anti-EGFR Tomuzotuximab (TO) in patients with EGFR positive solid tumors.
 
Sebastian Ochsenreither
Consulting or Advisory Role - Bristol-Myers Squibb; CureVac; Glenmark; Merck Sharp & Dohme
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen
 
Ulrich Keilholz
Honoraria - AstraZeneca; Bristol-Myers Squibb; Glycotope GmbH; Merck KGaA; MSD Oncology; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck Serono; MSD Oncology; pfizer
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Glycotope GmbH; Merck Serono; MSD Oncology; Novartis
Research Funding - Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Merck Serono; MSD Oncology
 
Konrad Friedrich Klinghammer
Consulting or Advisory Role - Bristol-Myers Squibb; Merck
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck
 
Christina Dicke
Travel, Accommodations, Expenses - Daiichi Sankyo; Pfizer; SOBI
 
Maxim Kebenko
No Relationships to Disclose
 
Elena Garralda
Consulting or Advisory Role - Roche
 
Josep Tabernero
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Genentech/Roche; Lilly; Merck Serono; MSD; Novartis; Roche; Sanofi; Symphony Evolution; Taiho Pharmaceutical
 
Ignacio Matos
No Relationships to Disclose
 
Domenica Lorusso
Honoraria - AstraZeneca; Clovis Oncology; Roche
Consulting or Advisory Role - Roche
Research Funding - Clovis Oncology; PharmaMar
 
Francesco Raspagliesi
No Relationships to Disclose
 
Luca Gianni
Consulting or Advisory Role - ADC Therapeutics; AstraZeneca; Boehringer Ingelheim; Celgene; Genomic Health; Lilly; Merck Sharp & Dohme; Odonate Therapeutics; Oncolytics; Onkaido Therapeutics; Pfizer; Roche; Sandoz; Sanofi; Seagen; Synaffix; Synthon; Taiho Pharmaceutical
Patents, Royalties, Other Intellectual Property - Roche
 
Gianluca Del Conte
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis
Travel, Accommodations, Expenses - Johnson & Johnson
 
Beate Habel
Employment - Glycotope GmbH
Patents, Royalties, Other Intellectual Property - Glycotope GmbH
 
Hans Baumeister
Employment - Glycotope GmbH
Stock and Other Ownership Interests - Glycotope GmbH
Patents, Royalties, Other Intellectual Property - Glycotope GmbH
 
Riccardo Belli
Employment - Glycotope GmbH
 
Alfredo Zurlo
Employment - Glycotope GmbH
Leadership - Glycotope GmbH
Stock and Other Ownership Interests - MOLOGEN
Honoraria - VAXIMM
Consulting or Advisory Role - VAXIMM
Patents, Royalties, Other Intellectual Property - MOLOGEN
 
Walter M. Fiedler
Consulting or Advisory Role - Amgen; ARIAD/Takeda; Jazz Pharmaceuticals; Novartis; Pfizer
Patents, Royalties, Other Intellectual Property - Amgen
Travel, Accommodations, Expenses - Amgen; Gilead Sciences; Jazz Pharmaceuticals; Teva